Cargando…

Contribution of Hepatitis C Infection to a Large Cohort of Cryoglobulin-Positive Patients: Detection and Characteristics

Cryoglobulins (CGs) are cold precipitating immunoglobulins, and hepatitis C virus (HCV) infection is its most common cause. The purpose of the study was to determine the contribution of HCV in a large cohort of CG. Biological characteristics and specificity of CGs in HCV patients were compared to no...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolopp-Sarda, Marie N., Miossec, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338377/
https://www.ncbi.nlm.nih.gov/pubmed/32695098
http://dx.doi.org/10.3389/fimmu.2020.01183
_version_ 1783554660933566464
author Kolopp-Sarda, Marie N.
Miossec, Pierre
author_facet Kolopp-Sarda, Marie N.
Miossec, Pierre
author_sort Kolopp-Sarda, Marie N.
collection PubMed
description Cryoglobulins (CGs) are cold precipitating immunoglobulins, and hepatitis C virus (HCV) infection is its most common cause. The purpose of the study was to determine the contribution of HCV in a large cohort of CG. Biological characteristics and specificity of CGs in HCV patients were compared to non-HCV subjects. Cryoglobulin analysis included isotype, clonality, concentration, and rheumatoid factor (RF) in cryoprecipitate and serum complement and RF. This study is an extension of the study carried out on a cohort of 13,439 patients tested for CGs from all medical units, in which 1,675/13,439 (12.5%) patients had a CG, and 680/1,675 (40.6%) had HCV serology or viral load determination (HCV RNA). Among these 680 CG patients tested for HCV, 325 of 680 (47.8%) HCV patients (272 HCV RNA(+) and 45 HCV RNA(−) patients) were compared to 355/680 (52.2%) non-HCV subjects. After a positive detection of CG, HCV status was determined only for 37.7% (256/680) of patients, allowing the diagnosis of a previously unknown HCV infection for 39.8% (102/256). Concentration of HCV RNA(+) CGs (median = 80.5 mg/L) was significantly higher than that of HCV RNA(−) CG (median = 50.5 mg/L, p = 0.001) and HCV(−) CG (median = 32 mg/L, p < 0.0001). There was no difference of median CG concentration between HCV RNA(−) patients and non-HCV subjects. Rheumatoid factor titer was significantly higher in type II CG compared to type III CG in HCV RNA(+) patients (254 ± 720 vs. 15 ± 21 IU/mL, p < 0.0001) and non-HCV subjects (333 ± 968 vs. 16.8 ± 26 IU/mL, p = 0.0004). Complement functional activity CH50 was lower in HCV RNA(+) patients (36 ± 24 U/mL) and in HCV RNA(−) patients (32 ± 21 U/mL) than in non-HCV subjects (50 ± 25 U/mL, p = 0.001 and p = 0.004). In conclusion, HCV infection and treatment influence CG characteristics. It is essential, and far from always tested, to determine the HCV status of patients with mixed CG, and conversely to search for CG in patients with HCV infection.
format Online
Article
Text
id pubmed-7338377
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73383772020-07-20 Contribution of Hepatitis C Infection to a Large Cohort of Cryoglobulin-Positive Patients: Detection and Characteristics Kolopp-Sarda, Marie N. Miossec, Pierre Front Immunol Immunology Cryoglobulins (CGs) are cold precipitating immunoglobulins, and hepatitis C virus (HCV) infection is its most common cause. The purpose of the study was to determine the contribution of HCV in a large cohort of CG. Biological characteristics and specificity of CGs in HCV patients were compared to non-HCV subjects. Cryoglobulin analysis included isotype, clonality, concentration, and rheumatoid factor (RF) in cryoprecipitate and serum complement and RF. This study is an extension of the study carried out on a cohort of 13,439 patients tested for CGs from all medical units, in which 1,675/13,439 (12.5%) patients had a CG, and 680/1,675 (40.6%) had HCV serology or viral load determination (HCV RNA). Among these 680 CG patients tested for HCV, 325 of 680 (47.8%) HCV patients (272 HCV RNA(+) and 45 HCV RNA(−) patients) were compared to 355/680 (52.2%) non-HCV subjects. After a positive detection of CG, HCV status was determined only for 37.7% (256/680) of patients, allowing the diagnosis of a previously unknown HCV infection for 39.8% (102/256). Concentration of HCV RNA(+) CGs (median = 80.5 mg/L) was significantly higher than that of HCV RNA(−) CG (median = 50.5 mg/L, p = 0.001) and HCV(−) CG (median = 32 mg/L, p < 0.0001). There was no difference of median CG concentration between HCV RNA(−) patients and non-HCV subjects. Rheumatoid factor titer was significantly higher in type II CG compared to type III CG in HCV RNA(+) patients (254 ± 720 vs. 15 ± 21 IU/mL, p < 0.0001) and non-HCV subjects (333 ± 968 vs. 16.8 ± 26 IU/mL, p = 0.0004). Complement functional activity CH50 was lower in HCV RNA(+) patients (36 ± 24 U/mL) and in HCV RNA(−) patients (32 ± 21 U/mL) than in non-HCV subjects (50 ± 25 U/mL, p = 0.001 and p = 0.004). In conclusion, HCV infection and treatment influence CG characteristics. It is essential, and far from always tested, to determine the HCV status of patients with mixed CG, and conversely to search for CG in patients with HCV infection. Frontiers Media S.A. 2020-06-30 /pmc/articles/PMC7338377/ /pubmed/32695098 http://dx.doi.org/10.3389/fimmu.2020.01183 Text en Copyright © 2020 Kolopp-Sarda and Miossec. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Kolopp-Sarda, Marie N.
Miossec, Pierre
Contribution of Hepatitis C Infection to a Large Cohort of Cryoglobulin-Positive Patients: Detection and Characteristics
title Contribution of Hepatitis C Infection to a Large Cohort of Cryoglobulin-Positive Patients: Detection and Characteristics
title_full Contribution of Hepatitis C Infection to a Large Cohort of Cryoglobulin-Positive Patients: Detection and Characteristics
title_fullStr Contribution of Hepatitis C Infection to a Large Cohort of Cryoglobulin-Positive Patients: Detection and Characteristics
title_full_unstemmed Contribution of Hepatitis C Infection to a Large Cohort of Cryoglobulin-Positive Patients: Detection and Characteristics
title_short Contribution of Hepatitis C Infection to a Large Cohort of Cryoglobulin-Positive Patients: Detection and Characteristics
title_sort contribution of hepatitis c infection to a large cohort of cryoglobulin-positive patients: detection and characteristics
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338377/
https://www.ncbi.nlm.nih.gov/pubmed/32695098
http://dx.doi.org/10.3389/fimmu.2020.01183
work_keys_str_mv AT koloppsardamarien contributionofhepatitiscinfectiontoalargecohortofcryoglobulinpositivepatientsdetectionandcharacteristics
AT miossecpierre contributionofhepatitiscinfectiontoalargecohortofcryoglobulinpositivepatientsdetectionandcharacteristics